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A B S T R A C T
Rationale and objective: Lung cancer is the most commonly diagnosed cancer and the leading cause of
cancer death in the world. In Central and South America lung cancer is now one of most frequent cancers
and the leading cause of cancer-related death in both sexes. We describe patterns and trends in lung
cancer incidence and mortality in Central and South America and give a brief overview of the current
status of tobacco control measures based on the most recent MPOWER report.
Methods: We obtained regional and national-level incidence data from 48 population-based cancer
registries in 13 countries and cancer deaths from the WHO mortality database for 18 countries. We
estimated world population age-standardized incidence and mortality rates per 100,000 person-years.
Incidence of lung cancer by histological subtype were only available from high-quality population-based
cancer registries for the period 2003–2007.
Results: The highest incidence and mortality rates in the region were seen among males in Argentina,
Cuba, Chile and Uruguay. Adenocarcinoma was the most frequent histological type overall, though
squamous carcinoma was more frequent in Antofagasta-Chile and Villa Clara-Cuba. Smoke-free policies
and warnings are widely implemented tobacco control measures; cessation is offered but the costs are
not covered by health systems in the majority of countries.
Conclusion: The high burden of lung cancer in the region highlights the need to improve long term
information and strengthen current tobacco control policies including aggressive taxing measures and
supporting smoking cessation in order to achieve the targeted reductions in smoking prevalence.
ã 2015 International Agency for Research on Cancer; Licensee Elsevier Ltd. This is an open access article
under the CC BY-NC-ND IGO 3.0 license (https://creativecommons.org/licenses/by-nc-nd/3.0/igo/).
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Lung cancer (comprising malignant tumors of the trachea,
bronchus and lung) is the most commonly diagnosed cancer in the
world. In 2012,1.8 million new lung cancer cases were estimated to
have occurred globally, accounting for almost 13% of all new cancer
cases (excluding non-melanoma skin cancer) [1]. In Central and
South America nearly 75,000 new cases are diagnosed each year$ This is an Open Access article published under the CC BY-NC-ND 3.0 IGO license
which permits users to download and share the article for non-commercial
purposes, so long as the article is reproduced in the whole without changes, and
provided the original source is properly cited. This article shall not be used or
reproduced in association with the promotion of commercial products, services or
any entity. There should be no suggestion that IARC endorses any speciﬁc
organisation, products or services. The use of the IARC logo is not permitted. This
notice should be preserved along with the article’s original URL.
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for Research on Cancer, 150 Cours Albert Thomas, 69008 Lyon, France.
E-mail address: pinerosm@iarc.fr (M. Piñeros).
http://dx.doi.org/10.1016/j.canep.2016.03.002
1877-7821/ã 2015 International Agency for Research on Cancer; Licensee Elsevier Ltd
creativecommons.org/licenses/by-nc-nd/3.0/igo/).and it is the second most common cancer among men (9.6% of the
total) after prostate cancer and the fourth most common among
women (5.5% of the total) [1]. With almost 1.6 million cancer
deaths, it is also the leading cause of death from cancer in the world
(19% of all cancer deaths); similarly, in Central and South America it
also represented the leading cause of death among both sexes
accounting for 12% of all cancer deaths (65,736 overall) [1].
Although, among men, a gradual decline in lung cancer
mortality rates has been reported in the past few decades in
Central and South America, mortality for this malignancy has been
increasing among women in most countries in the region [2,3].
Thus, a recent comparative study in 11 Latin American countries,
examining cancer mortality from 1980 to 2010, indicated
decreasing lung cancer mortality rates among men in all countries
with the exception of Colombia, Cuba and Venezuela. In women,
lung cancer mortality rose by 1% to 3% per year in all Latin
American countries except Mexico and Costa Rica [3].
Given the overwhelming evidence concerning tobacco smoking
as, by far, the principle risk factor for lung cancer, much of the
interpretation in changing lung cancer incidence (or mortality). This is an open access article under the CC BY-NC-ND IGO 3.0 license (https://
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and, related to this, governmental efforts to reduce smoking
prevalence. Unfortunately, in the Latin American region, there is a
lack of information concerning both long-term trends in lung
cancer incidence as well as long-term smoking prevalence. The call
on governments, by the 2013 WHO Assembly, to reduce the
prevalence of smoking by about a third by 2025 [4], poses
important challenges including long-term assessment of its
prevalence. To help governments implement the WHO Framework
Convention on Tobacco Control (WHO FCTC), a set of six public
health tobacco control measures was launched in 2008 under the
name of MPOWER [5].
In this paper, we aim to provide a comprehensive picture of the
overall burden, patterns and trends in lung cancer incidence and
mortality in Central and South America together with a general
overview of the advances regarding the MPOWER tobacco control
measures within the region.
2. Material and methods
In the present analysis lung cancer was coded as C33-
34 according to 10th edition of the International Classiﬁcation
of Diseases (ICD-10). Until the year 1991, the underlying cause of
death was categorized according to the ICD 9th revision however
all data were converted to the ICD 10th revision. The data sources
and methods are described in detail in an earlier article in this
issue. In brief, we obtained regional and national-level incidence
data from 48 population-based cancer registries in 13 countries
and cancer deaths from the World Health Organization mortality
database for 18 countries. We estimated age-standardized inci-
dence (ASR) and mortality (ASMR) rates per 100,000 person-years
using the direct method and the World standard population, as
proposed by Doll et al. [6,7]. We estimated national ASRs by
aggregating the data from the available cancer registries using a
weighted average of local rates. To describe incidence and
mortality time trends, we calculated the estimated annual percent
change (EAPC) using the method proposed by Esteve et al. [8].
Trends in incidence and mortality and EAPCs were estimated only
for 4 countries (Table 1). All of the EAPCs were tested for equality to
zero by using the corresponding standard errors. We considered
EAPCs statistically signiﬁcant if the p-value 0.05. We conducted
the data analysis in Stata version 12.1 (StataCorp) [9].
In addition to the general methods described above, we
considered information by histological subtype as coded in ICD-
O-3. Unfortunately, this information was incomplete for most
registries in the region and we decided to include, for this analysis,
only registries which qualiﬁed for publication in CI5 volume X [10].
Given the importance of tobacco smoking as a risk factor we
also provide an overview of smoking prevalence and tobacco
control measures in the region. Information on adult and
adolescent tobacco smoking prevalence was taken from the Global
Health Observatory Data Repository [11,12]. Information on the
advancement of prevention policies was taken from the last
available WHO reports on the global tobacco epidemic [2013, 2015]
following the MPOWER components, which represent six publicTable 1
Countries and cancer registries included in the analysis of time trends.
Country Name of registries included 
Argentina Bahia Blanca 
Brazil Aracaju, Fortaleza, Goiania, Sao Paulo 
Chile Valdivia 
Costa Rica National registry health policy measures that have been established by the WHO
FCTC to assist countries in the implementation of effective
interventions to reduce the demand for tobacco [13].
3. Results
3.1. Age-standardized incidence and mortality rates
In the region, lung cancer incidence rates (per 100,000) ranged
from as high as 50.1 among males in Uruguay, to as low as
1.1 among females in El Salvador. In Central America, Cuba had by
far the highest incidence of lung cancer for both males and females
(39.2 and 18.9, respectively), with lung cancer also ranking in the
ﬁrst place for cancer incidence among males. The South American
countries where the highest male incidence rates were observed
were the so-called “Cono Sur” countries: Uruguay (50.1), Chile
(33.8) and Argentina (30.5); in all three countries lung cancer
ranked second for male cancer incidence. Among females, the
pattern was slightly different with the highest incidence rates
found in Chile (12.1) and Brazil (11.5). The highest male-to-female
incidence ratio was found in Uruguay (5.5) and the lowest in
Bolivia (0.6) (Table 2).
For mortality, the countries with the highest rates (per
100,000), among both males and females in Central America,
were Cuba (39.0 and 18.1), Belize (15.9 and 6.5) and Mexico
(13.2 and 5.4). Among males, lung cancer mortality ranked in the
ﬁrst two places in half of the Central American countries and in 80%
of the South American countries. In the latter, male mortality
patterns closely followed those for incidence, with the highest
rates (per 100,000) in Uruguay (44.5), Argentina (30.8) and Chile
[18]. In females the pattern was slightly different; countries with
the highest lung cancer mortality rates were Venezuela (9.3),
Argentina (7.8), Colombia (7.7) and Brazil (7.6). In almost all
countries, mortality rates were very similar to incidence rates with
the exception of Peru, where female lung cancer mortality rates
were only half (4.7) those of the incidence rates (8.9). The highest
male-to-female mortality ratios were found in Uruguay (6.1) and
the lowest in El Salvador, Guatemala and Peru (ratios from 1.4 to
1.5) (Table 2).
3.2. Time trends
In Argentina, Brazil, Chile and Costa Rica, there was a decline in
lung cancer incidence and mortality rates among males for the
1997–2007 period (Fig. 1). The reduction in incidence was only
statistically signiﬁcant in Argentina and Brazil, with estimated
annual percent changes of 5.2% and 3.8%, respectively (Fig. 2).
Incidence rates among females in Argentina and Chile also
declined over time, with an estimated annual percent change
that ranged from 4.6% to 1.4% respectively, though these
changes were not statistically signiﬁcant. Lung cancer incidence in
Costa Rican females remained almost constant over time, while
mortality showed a decreasing trend for both male and females. In
contrast, there was an increase in lung cancer mortality rates over
time among females in Brazil, Argentina and Chile, although thesePeriod % of the population covered
1993–2007 0.8
1997–2006 8
1993–2008 2.2
1985–2007 100.0
Table 2
Lung cancer age-standardized incidence and mortality rates (per 100,000) in Central and South America.
Country by Subregion Incidence Mortality
Period Sex Cases Crude rate ASR (W) Ranka M:F Deaths Crude rate ASR (W) Ranka M:F
Central America
Belize 2003–07 Male – – – – 60 8.7 15.9 2 2.4
Female 24 3.4 6.5 4
Costa Rica 2003–07 Male 934 8.6 10.5 4 2.2 819 7.5 8.9 4 2.2
Female 453 4.3 4.7 10 399 3.8 4 5
Cubab 2004–07 Male 1022 62.3 39.2 1 2.1 12225 54 39 1 2.2
Female 501 31.1 18.9 2 6059 27.1 18.1 1
El Salvadorb 1999–03 Male 125 1 1.3 8 1.2 507 3.5 4.9 3 1.4
Female 134 0.9 1.1 11 457 3 3.4 5
Guatemala 2003–07 Male – – – – 1125 3.6 5.9 4 1.5
Female 849 2.6 3.9 4
Mexicob 2006–10 Male 814 4.8 6.1 3 1.8 21875 7.9 13.2 2 2.4
Female 507 2.9 3.3 9 11298 3.8 5.4 6
Nicaragua 2003–07 Male – – – – 400 3 5.2 4 1.6
Female 277 2 3.2 5
Panama 2003–07 Male – – – – 834 10.2 12.2 2 2.5
Female 371 4.6 4.9 4
South America
Argentinab 2003–07 Male 3710 30.1 30.5 2 3.8 32389 34.2 30.8 1 3.9
Female 1257 9.7 8 6 10598 10.7 7.8 4
Boliviab 2011 Male 18 1.4 1.4 7 0.6 . . . .
Female 29 2.1 2.2 9 . . . .
Brazilb 2003–07 Male 11049 19.8 26.8 3 2.3 59696 13 15.9 1 2.4
Female 6779 11 11.5 6 30854 6.6 6.7 3
Chileb 2003–07 Male 703 30 33.8 2 2.8 7324 18.2 18 2 2.4
Female 298 13.4 12.1 5 4060 9.9 7.6 5
Colombiab 2003–07 Male 1237 13.6 15.4 3 2.0 11100 10.5 15.1 2 2.0
Female 832 8.3 7.8 7 7154 6.6 7.7 5
Ecuadorb 2003–07 Male 288 6.1 7.5 5 1.4 1726 5.1 6.4 3 1.7
Female 246 4.8 5.2 11 1131 3.4 3.8 5
French Guyanab 2003–08 Male 70 14.1 21.3 2 2.6 . . . .
Female 28 5.6 8.3 6 . . . .
Paraguay 2003–07 Male – – – – 1365 9.2 13.7 1 4.3
Female 353 2.4 3.2 4
Perub 2001–05 Male 1001 10.9 11.8 3 1.3 3335 4.9 6.8 3 1.4
Female 835 8.7 8.9 5 2650 4 4.7 5
Suriname 2003–07 Male – – – – 126 10.1 12.8 2 2.6
Female – – – – 60 4.8 5 3
Uruguay 2005–07 Male 3193 66.5 50.1 2 5.5 2904 60.3 44.5 1 6.2
Female 731 14.2 9.1 5 614 11.9 7.2 2
Venezuela 2003–07 Male – – – – 8382 12.5 17.3 2 1.9
Female 5065 7.6 9.3 3
ASR (W), age-standardized (World population) rate per 100,000. M:F, male-to-female ratio.
a Rank based on highest ASR excluding: All sites but C44 and All sites.
b Incidence rates were estimated using data from regional cancer registries.
S92 M. Piñeros et al. / Cancer Epidemiology 44S (2016) S90–S99were not statistically signiﬁcant. Costa Rica had the lowest lung
cancer incidence and mortality when compared to Argentina,
Brazil and Chile. Notably, before 1997 lung cancer mortality in
Costa Rica was higher than incidence, among both males and
females (Fig. 2).
3.3. Distribution by histological group
The information from Central and South American population-
based cancer registries included in Cancer Incidence in Five
Continents (CI5) Vol. X [14] indicates that, for 2003–2007, less than
70% of lung cancers were microscopically veriﬁed and almost 20%
of new cancer cases were included using only death certiﬁcation
(Tables 2 and 3). Overall, age-standardized rates among males were
higher for adenocarcinoma than for other subtypes, except in
Antofagasta (Chile) and Villa Clara (Cuba), where squamous cell
carcinoma was the subtype with highest rates among both males
and females (Tables 3 and 4). In Uruguay, squamous cell was the
most frequent subtype among males whilst in Tierra del Fuego
(Argentina) the highest rates among males were for large cell
carcinoma.3.4. Smoking prevalence and advances in tobacco control measures
Tobacco use, particularly smoking (including passive smoking),
is overwhelmingly the predominant cause of lung cancer
worldwide and is the cause of more preventable cancer deaths
than any other known risk factor [15]. According to WHO
estimates, 265,000 deaths can be attributed to tobacco smoking
in Latin America and The Caribbean [16].
The most recent estimates, available from the WHO Global
Health Observatory Data Repository (WHO GHO), indicate that in
Central & South America among adults (15 years) the highest
smoking prevalences (above 40% in males) occurred in Chile,
Bolivia, Argentina, and Cuba; while among adolescents (13 to
15 years) they were in Chile, Ecuador, and Nicaragua (Fig. 3a and b).
Eight of the 21 countries included in the WHO GHO had no
information for tobacco prevalence among adults; in all included
countries with information available from two or more surveys,
smoking prevalence decreased among adults between 2000 and
2010. This was, however, not the case among adolescents (Fig. 3a
and b).
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prevalence over longer periods of time, comparable information
on temporal variations in smoking prevalence for more than
10 years within countries in the region is scarce. A recent
publication including a comparison between Uruguay (thatintroduced a strict tobacco control policy) and Argentina, showed
a statistically signiﬁcant annual decrease of 3.3% (95% CI 2.4–4.1) in
the prevalence of current use of tobacco in Uruguay, compared to a
non-signiﬁcant annual decrease of 1.7% (95%CI 0.8 to 2.6) in
Argentina [17].
Table 3
Male lung cancer age-standardized (World population) incidence rates (per 100,000) of microscopically veriﬁed cases by histological type within Central and South American
population-based cancer registries.
Country Registry Carcinoma Sarcoma Other Unspec. Number of cases
Squamous Adeno Small cell Large cell O&U MV Total
Argentina Bahia Blanca 5.5 10.4 2.2 6.0 0.2 – – 3.3 226 317
Cordoba 5.5 7.6 2.1 3.0 2.0 0.1 0.1 1.2 560 775
Mendoza 4.9 4.9 2.0 4.1 1.9 0.0 0.0 1.6 817 1121
Tierra del Fuego 6.1 7.0 2.2 7.6 1.4 – – 0.8 46 61
Brazil Aracaju 6.6 6.1 1.2 2.7 1.3 – – 0.6 105 145
Belo Horizonte 4.0 5.7 1.6 2.5 0.7 0.0 – 0.9 393 556
Cuiaba 3.6 4.4 1.3 3.7 0.6 0.0 – 1.5 128 196
Fortaleza 3.6 6.8 1.1 2.8 0.3 0.0 – 1.8 449 626
Goiania 6.7 8.5 2.6 3.6 1.6 0.1 0.0 1.8 471 570
Sao Paulo 4.2 6.2 1.4 4.7 1.4 0.1 0.0 0.0 3831 5484
Chile Biobio 1.0 1.4 0.1 0.3 0.1 – – 0.8 37 88
Region Antofagasta 14.3 2.7 2.5 10.3 0.4 – – 0.5 334 592
Valdivia 2.2 1.3 0.7 1.1 0.1 – – 0.4 58 106
Colombia Bucaramanga 2.6 1.8 0.6 1.4 0.0 – – 0.7 143 237
Cali 2.5 3.3 1.1 2.8 1.6 0.1 0.0 0.6 502 808
Manizales 5.5 3.4 0.7 2.3 – – – 0.4 106 130
Pasto 1.6 1.4 0.4 0.4 0.2 – – 0.2 31 58
Costa Rica Costa Rica 2.0 1.9 0.9 1.1 0.3 0.0 – 0.2 566 933
Cuba Villa Clara 8.0 4.5 1.1 7.6 0.1 0.1 – 2.1 569 1020
Ecuador Cuenca 0.3 1.0 0.1 0.8 0.6 – – 0.3 26 47
Quito 1.7 2.7 0.3 0.9 0.2 – – 0.3 173 241
Uruguay Uruguay 8.6 8.5 3.4 5.8 3.1 0.0 – 0.3 1826 3187
O&U, other and unspeciﬁed; MV, microscopic veriﬁcation; Unspec, unspeciﬁed.
Source: Cancer Incidence in Five Continents, Volume X [14].
Table 4
Female lung cancer age-standardized (World population) incidence rates (per 100,000) of microscopically veriﬁed cases by histological type within Central and South
American population-based cancer registries.
Country Registry Carcinoma Sarcoma Other Unspec. Number of cases
Squamous Adeno Small cell Large cell O&U MV Total
Argentina Bahia Blanca 0.3 2.6 0.3 1.9 0.5 – – 1.0 68 96
Cordoba 1.3 3.4 0.7 0.6 0.8 – – 0.3 243 350
Mendoza 0.8 1.8 0.5 0.8 0.5 0.1 – 0.4 242 352
Tierra del Fuego 0.3 2.0 1.4 1.8 0.7 – – 0.7 13 15
Brazil Aracaju 2.1 3.3 1.0 0.6 0.8 – – 0.3 67 83
Belo Horizonte 0.9 2.5 0.7 0.6 0.5 – – 0.2 207 293
Cuiaba 1.3 1.3 1.0 1.7 0.1 – – 0.7 58 94
Fortaleza 0.9 4.4 1.0 1.2 0.2 – – 0.9 341 469
Goiania 2.3 5.4 1.4 1.4 0.7 – 0.0 0.9 301 358
Sao Paulo 1.2 3.3 0.7 2.1 0.7 0.0 0.0 0.0 2406 3404
Chile Biobio Province 0.2 1.1 0.2 – 0.1 – – 0.1 18 44
Region of Antofagasta 4.5 2.1 1.0 3.0 0.2 – – 0.6 138 242
Valdivia 0.3 1.2 – 0.6 – – – 0.2 25 54
Colombia Bucaramanga 1.0 1.5 0.2 0.9 0.1 0.1 – 0.5 110 184
Cali 0.9 2.3 0.3 1.4 0.8 0.0 – 0.2 322 509
Manizales 2.1 2.0 0.8 1.2 0.1 – – 0.2 74 98
Pasto 0.3 0.7 – 0.4 0.4 – – 0.1 19 37
Costa Rica Costa Rica 0.7 1.5 0.3 0.4 0.3 0.0 0.0 0.1 297 450
Cuba Villa Clara 3.9 2.8 0.8 3.8 – – – 0.7 292 501
Ecuador Cuenca 0.1 0.7 – 0.2 0.1 – – 0.2 15 29
Quito 0.6 3.0 0.2 0.5 0.3 0.0 – 0.2 159 217
Uruguay Uruguay 1.1 2.5 0.8 1.0 0.6 – – 0.1 441 728
O&U, other and unspeciﬁed; MV, microscopic veriﬁcation; Unspec, unspeciﬁed.
Source: Cancer Incidence in Five Continents, Volume X [14].
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Fig. 3. Current smoking of any tobacco product (age-standardized rate) in Central and South America for adults (a) and adolescents (b).
Source of data: WHO Global Health Observatory Data Repository (11;12).
M. Piñeros et al. / Cancer Epidemiology 44S (2016) S90–S99 S95The status of the WHO FCTC as of May 2015 indicated that all
the Central and South American countries signed and ratiﬁed the
Convention except for Cuba and Argentina, who signed but did not
ratify the FCTC [18,19]. Regarding the different MPOWER (acronym
described below) components, the WHO 2013 and 2015 reports
indicated the following information [13,20]:
3.4.1. Monitor tobacco use and prevention policies (M)
The Global Adult Tobacco Survey (GATS), using a standard
methodology, has been implemented since 2009 in Argentina,
Brazil, Mexico, Panama, and Uruguay. These surveys showed the
highest smoking prevalence (current smoking) among men and
women in Uruguay and Argentina (31% and 29% in men; and 20%
and 16% in women, respectively) and the lowest in Panama among
men (17.6%) and in Belize among women (1.4%) [21,22]. All
countries in the region have performed the Global Youth Tobacco
Survey (GYTS), which started in 1999, either with national or local/
city representation [23]. The GYTS Global School Personnel Survey
(GSPS), which started in 2000, has been completed in Dominican
Republic, Guyana, México, Panamá, Paraguay, Surinam and
Uruguay whereas the Global Health Professions Students Survey
(GHPSS), has been completed in 11Central and South American
countries, as well as in Cuba [24].
3.4.2. Protecting people from tobacco smoke (P)
As of 2014, the following thirteen Central and South American
countries had implemented smoke free policies with all public
places completely smoke free or at least 90% of the population
covered by complete sub-national smoke-free legislation:
Argentina, Brazil, Chile, Colombia, Costa Rica, Ecuador, Guatemala,
Honduras, Panama, Peru, Suriname, Uruguay, and Venezuela [20].
In the same 2015 report, a positive change in different MPOWER
indicators regarding smoke-free policies was seen in comparison
with the 2012 report in Chile and Suriname. Despite the existence
of smoke free policies, the GATS survey revealed that second hand
smoke exposures in Uruguay were 16.5% in the workplace, 6.9% in
government buildings, 4.4% in restaurants, 5.4% on public
transportation and 3.8% in healthcare facilities [25].3.4.3. Cessation (O)
Most countries in the Central and South American region offer
nicotine replacement therapy (NRT) and some cessation services,
though in many countries their costs are not covered by the health
systems [13]. By 2014, Argentina, Brazil, El Salvador, Mexico,
Panama and Uruguay reported having national quit lines and both
NRT and some cessation services covered the costs [13].
3.4.4. Warnings (W)
Almost all Central and South American countries have
implemented warning labels on cigarette packages; although
not all countries fulﬁll the warning label’s characteristics (i.e. direct
health message and large graphic pictorial warning covering more
than half of the box). As of May 2013, no warnings have been
implemented on cigarette packages in Guatemala, Guyana and
Paraguay [13].
3.4.5. Bans on advertising & promotion (E)
Brazil, Colombia, Panama, Suriname and Uruguay are the
countries in the region that have implemented a ban on all forms of
direct and indirect advertising. In addition, they have provided
data regarding good compliance with this regulation [13].
3.4.6. Taxation (R)
Share of total taxes (%) in the average retail price of cigarettes
varied widely in the Central and South American region, from 16%
in Paraguay to 81% in Chile; the percentage was below 50% in three
Central American countries and ﬁve South American countries
(Fig. 4) [13].
4. Discussion
The present results show that lung cancer represents an
important cause of morbidity and mortality in the region ranking
among the ﬁrst most common causes of cancer, particularly among
men. Lung cancer incidence rates vary substantially and show a
clear differentiated pattern with the highest incidence occurring in
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same pattern was observed for tobacco consumption.
The highest incidence rates reported in the region among males
in Uruguay and Cuba, are similar to those observed in Bulgaria and
in other eastern European countries and to Hispanic male
populations in the USA [14,26]. Furthermore, in Uruguay, available
information on lung cancer incidence by region shows districts
where the age-adjusted incidence rates can reach values that are as
high as 80 per 100,000 [27]. In contrast, the strikingly low
incidence rates observed in Costa Rica are likely to reﬂect the low
smoking prevalence in the country, particularly among females
[28].
Regarding mortality estimates, for Cuba our results are similar
to those reported by Loria and colleagues for the period 2001–2005
[29] whereas, for Mexico, rates were higher than those reported by
Tovar-Guzmán et al. [30] for 2000 (8.7 among men, and 3.6 among
women); this may reﬂect differences in the length of periods
evaluated and therefore stability of estimates (1 year versus
5 years). Female mortality rates observed in Argentina and
Colombia were also higher than those previously reported by
Loria et al. [27] and Piñeros et al. [28] which probably relates to the
slight increase in lung cancer mortality observed in the last few
years among women.
The strong differences in the magnitude of lung cancer
incidence and mortality rates observed in Peru, particularly among
females (where incidence almost doubles mortality), may imply
either incomplete mortality data, duplication of cases in the
registries included, or registration in areas that do not represent
the national pattern. These could also be factors inﬂuencing the
differences observed in the ranking between incidence andmortality encountered in several of the countries, in a cancer that
is known to have a high fatality rate.
Overall (with the exception of Bolivia), lung cancer incidence
and mortality rates were higher in males being consistent with the
observed pattern in most countries of the world [1]. The only
exception was Bolivia with a male-to-female incidence ratio of
0.65; these results should be treated with caution given the small
numbers they were based on as a result of the recent resumption of
activities at the Cancer Registry of La Paz.
The observed decreasing lung cancer incidence trends among
men in the four countries analyzed, particularly those from
Argentina and Brazil are consistent with decreasing trends
observed in regional cancer registries like the ones in Cali and
Pasto in Colombia [31,32]. In Brazil, a substantial reduction in
smoking prevalence has been reported by different studies
particularly among men [33,34], that could be related to the
observed decreases in lung cancer incidence among males. In
Argentina, there is evidence of a small decrease in smoking
prevalence for a more recent time period [2005–2011] [17] that
could contribute to the observed trends among males, under the
assumption that smoking has been decreasing for a longer period.
Nevertheless, among females the observed decreasing incidence
trends in Argentina and Brazil should be interpreted with caution
as they are not statistically signiﬁcant, and, in addition, signiﬁcant
increasing mortality rates have been reported among females in
almost all countries of the region [3]. This contradiction could be
explained by the fact that the incidence rates used in this project
are a summary measure of participating cancer registries at a
country level and do not represent more than 20% of the country’s
population.
The overall higher rates of adenocarcinoma observed in many
countries are in accordance to the changing patterns described
internationally among men, where the former predominant
subtype of squamous cell carcinoma has been replaced by
adenocarcinoma in several countries [35–39]. These changes have
been related to the shifts in cigarette manufacturing (introduction
of ﬁlters and reduced tar content) and to the effects of smoking
cessation and reduction in smoking prevalence [37,40]. The
substantial higher squamous carcinoma rates found in Antofa-
gasta, Chile, coincide with the particularly high smoking preva-
lence ﬁgures reported in this country and in the speciﬁc region
[41], considering the strong relationship of smoking with small-
cell lung cancer and squamous-cell carcinoma. In addition,
occupational and environmental exposures could be contributing
to the different lung cancer histology distribution given the mining
activity (particularly in Antofagasta) as well as the presence of
arsenic in drinking water, which has been identiﬁed in the region
[42–46].
Regarding tobacco control measures, overall, implementation
of MPOWER activities shows some advances in the region. Within
the Global Tobacco Surveillance system it is noteworthy that all
countries have implemented the GYTS, with many having already
had two measurements. In contrast, only few have implemented
GATS, a fact that will deﬁnitely hamper the measurement
concerning the expected 30% reduction in prevalence of tobacco
use by 2025 persons aged 15 years and more [47]. The more
extensive coverage by GYTS might be related to an easier
implementation process given the context in which these surveys
are applied (in schools). One aspect to consider in many countries
as a potential barrier for the wider adoption of GATS is the
multiplicity of co-existing surveys that measure smoking preva-
lence, either as part of independent studies, of major national
psychoactive substances surveys or of national household surveys.
A systematic review identiﬁed more than 59 studies in Brazil
between 1990 and 2009 measuring both tobacco and alcohol
consumption in adolescents aged between 10 and 18 years [48].
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ages and showed slight differences in the comparability of
questions, highlighting important challenges for overall compara-
bility of different surveys within and between countries. In
addition, in the region only a few countries have longstanding
information on adult tobacco consumption hindering long term
comparability of smoking prevalence and its relation to lung
cancer burden, particularly considering the substantial time lag
between smoking and development of a cancer. In resource-
constrained settings, focusing on adult prevalence surveys might
be preferable as, the age-group of the GYTS survey (13–15 years) is
very young if one considers that the mean age of acquiring a
tobacco dependency (becoming a daily smoker) is slightly less than
18 years, even if teenage consumption has increased [49,50].
The establishment of smoke- free policies was among the
MPOWER components with the highest implementation rates
across all countries, a signiﬁcant achievement considering the
effects of legislative smoking bans on improved health outcomes
and reduction of mortality from smoking related diseases at
national levels [51]. Despite these promising perspectives, caution
is recommended: in Uruguay, where important decreases in
smoking prevalence have followed the introduction of a strict
smoke-free policy [17], the GATS survey indicates a relative high
proportion of tobacco smoke exposure in the workplace [25].
Furthermore, there is evidence from both Uruguay and Mexico that
workplaces and bars display higher passive smoke exposure rates
compared to restaurants after policy introduction [52].
In contrast to the wide adoption of smoke-free policies,
implementation of practices to increase cessation levels was less
widespread with few countries covering the costs of treatments;
these results are of particular concern given not only the observed
beneﬁts of smoking cessation [53], but also the direct relationship
between smoking and lower socioeconomic conditions. A Brazilian
study among smokers that wanted to quit showed a clear inequity
with disadvantages for smokers from lower socioeconomic back-
grounds in the frequency of visits to the doctor and the counselling
received [54] compared to those from higher socioeconomic
conditions. The need for improving support to access for
medication has been noted in a previous comprehensive analysis
of tobacco control measures in the region [55].
Increasing the price of cigarettes is the main driving force in
decreasing tobacco sales and per capita consumption [56] with
excise taxes playing a determinant role. Nevertheless, there is
evidence for Brazil showing that tax and pricing policies have been
developed more slowly than other measures [57]. Estimates for
Mexico show that a 10% increase in cigarette price may reduce
consumption by 2.5% [58], and more recent estimates indicate that
increase in prices could be responsible of more than 60% of the
smoking reduction achieved since 2002 [59]. A low excise tax on
tobacco is the main reason that cigarettes are about 70% cheaper
(even after adjustment for purchasing power) in many low income
countries than in high-income countries [53]. The MPOWER report
showed important variations in the shares of total taxes in the
retail price of the most widely sold brands of cigarettes, with eight
countries below 50%. However, the highest proportions were
observed in Chile and Cuba, a result which does not correspond
with the fact that these two countries have the highest smoking
prevalence in the region. This highlights the need for additional
information at a country level that explains the results and
variability in the implementation of tobacco control policies, as has
been suggested in a recent Latin American comparative analysis
[60].
Some limitations of the present study are the absence of
national data, resulting most probably in underestimation of
incidence rates, particularly in high-populated countries. In
addition, the quality of incidence data deserves caution forinterpretation; in some countries our descriptions were based
solely on mortality data, the limitations of which are well-known.
Finally, in most countries there was an inability to correlate
smoking prevalence time trends with lung cancer time trends due
to lack of data.
Despite these limitations, we provide a regional perspective on
the burden and patterns of one of the most important cancers in
the proﬁle of countries as well as a broad overview of main tobacco
control measures implemented. Future developments, implemen-
tation research and improvement of cancer information, particu-
larly of population- based cancer registries as well as monitoring
tobacco consumption in a comparable way – particularly among
adults – are a priority to plan and evaluate tobacco control
activities in the region and in each country. Furthermore,
additional efforts to strengthen and improve the implementation
of tobacco control measures are required – particularly in the areas
of taxes and cessation – in order to reduce preventable deaths in a
broad spectrum beyond lung cancer, and thus contribute to the
attainment of the overall 25% reduction of mortality from non-
communicable diseases target by 2025 [47].
5. Conclusions
Lung cancer is one of the leading causes of death (among all
cancers) in the Central and South American region and is among
the most common incident cancers, particularly in males,
occurring three times more frequently than in females in almost
all countries of the region. In the majority of cancer registries
where data of sufﬁcient quality are available, adenocarcinoma is
the most prevalent histological type, though still in many registries
it is squamous carcinoma, particularly in Antofagasta (Chile) and
Villa Clara (Cuba).
Patterns of lung cancer incidence are mainly determined by
previous exposure to tobacco smoke. Unfortunately, the lack of
long-term trends in lung cancer incidence available to compare
with long-term smoking trends did not permit observation of
changes that could correspond to the four stages described in the
tobacco epidemic [61]. There is a clear need in the region to
improve the available information in order to monitor trends in
burden (both incidence and mortality) and smoking patterns
(particularly among adults) for longer periods, linking it to the
implementation of tobacco control policies.
Despite successful adoption and implementation of tobacco
control measures contained in the MPOWER package combined
with decreasing smoking prevalence ﬁgures in several countries
of the region, there remains a need for governments to strengthen
tobacco control measures in order to achieve the 30% reduction in
tobacco use among persons aged 15+, set in the WHO NCD 2013–
2020 Global Action Plan (62). Speciﬁc areas where clear
additional efforts are needed at country level are the implemen-
tation of GATS, increasing taxes, offering help to quit tobacco and
promoting research to identify barriers and determinants for
successful implementation of tobacco free policies. Areas where
population-based cancer registries exist provide a privileged
scenario to plan and evaluate the long-term impact of tobacco
control measures.
Authors contribution
Study conception and design: DF, MS, MP
Acquisition of data: MS
Analysis and interpretation of data: MP, MS, DF
Writing the article: MP
Critical revision of the article: MP, MS, DF
Final approval of the article: MP, MS, DF
S98 M. Piñeros et al. / Cancer Epidemiology 44S (2016) S90–S99Conﬂict of interest
None.
Funding
This work was undertaken during the tenure of a Postdoctoral
Fellowship to Dr Mónica S. Sierra from The International Agency for
Research on Cancer, partially supported by the European
Commission FP7 Marie Curie Actions – People – Co-funding of
regional, national and international Programmes (COFUND).
Acknowledgements
The authors would like to thank sincerely all of the cancer
registry directors and their staff (listed in the Appendix to the
Introduction of this Supplement) for their considerable efforts in
collecting the data presented in this paper, together with members
of the IARC Section of Cancer Surveillance, especially Sebastien
Antoni, Murielle Colombet and Mathieu Laversanne for their
collaboration. The authors also wish to acknowledge Dr Esther de
Vries and Dr Marise Rebelo for their valuable comments in
reviewing earlier drafts of the manuscript.
References
[1] J. Ferlay, I. Soerjomataram, M. Ervik, R. Dikshit, S. Eser, C. Mathers, et al.,
GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC
CancerBase No.11 [Internet]. 2013 Available from: URL: http://globocan.iarc.fr.
[2] C. Bosetti, M. Malvezzi, L. Chatenoud, E. Negri, F. Levi, V.C. La, Trends in cancer
mortality in the Americas, 1970–2000, Ann. Oncol. 16 (March (3)) (2005) 489–
511, doi:http://dx.doi.org/10.1093/annonc/mdi086.
[3] L. Chatenoud, P. Bertuccio, C. Bosetti, M. Malvezzi, F. Levi, E. Negri, et al., Trends
in mortality from major cancers in the Americas: 1980–2010, Ann. Oncol.
(June) (2014), doi:http://dx.doi.org/10.1093/annonc/mdu206.
[4] World Health Organization, Draft Comprehensive Global Monitoring
Framework and Targets for the Prevention and Control of NCDs 2013, WHO,
Geneva, 2013.
[5] World Health Organization, WHO Report on the Global Tobacco Epidemic,
2008. The MPOWER Package, World Health Organization, 2015. (20-5-2015)
http://www.who.int/tobacco/mpower/gtcr_download/en/index.html.
[6] R. Doll, P. Payne, J. Waterhouse, Cancer Incidence in Five Continents. Vol I. [I].
1966. Geneva, Union Internationale Contre Le Cancer. Ref Type: Serial (Book,
Monograph).
[7] M. Segi, M. Kurihara, T. Daigaku, Trends in cancer mortality for selected sites in
24 countries, 1950-1959. Tohoku University School of Medicine, editor. 1963.
[8] J. Esteve, E. Benhamou, L. Raymond, Statistical methods in cancer research,
Descriptive epidemiology. 1-302. IARC, Volume IV, IARCScientiﬁc Publications,
1994, pp. 128.
[9] Stata data analysis and statistical Software. Version 12.1. StataCorp, L P 2011.
[10] D. Forman, F. Bray, D. Brewster, Gombe Mbalawa Ch, B. Kohler, M. Piñeros, et al.,
Cancer incidence in ﬁve continents, IARC Scientiﬁc Publication No. 164, vol. X,
International Agency for research on cancer and International Association of
Cancer Registries, Lyon, 2014.
[11] WHO Global Health Data Repository, Prevalence of Smoking Any Tobacco
Product Among Persons Aged > = 15 Years, WHO Global Health Data
Repository, 2014. (10-6-2015) http://apps.who.int/gho/data/node.
metadata.18?lang=en.
[12] WHO Global Health Data Repository, Prevalence of smoking any tobacco
product among persons aged 13–15 years, WHO Global Health Data
Repository, 2015 20-6-2015.
[13] World Health Organization, WHO report on the global tobacco epidemic 2013,
Appendix I: Regional summary of MPOWER measures, World Health
Organization, 2013. (cited 2014 Aug 27) http://www.who.int/tobacco/
global_report/2013/en/2014.
[14] D. Forman, F. Bray, D. Brewster, Ch. Gombe Mbalawa, B. Kohler, M. Piñeros,
et al., Cancer Incidence in Five Continents, vol. X, IARC, Lyon, 2013. (electronic
version) http://ci5iarcfr.
[15] A. Jemal, P. Vineis, F. Bray, D. Torre Lorman, The Cancer Atlas, second ed.,
American Cancer Society, Atlanta, GA, 2014.
[16] World Health Organization, Risk Factors Estimates for 2004: Attributable
Deaths by World Bank Regions for the Year 2004, World Health Organization,
2004. (cited 2016 Feb 29) http://www.who.int/healthinfo/
global_burden_disease/risk_factors/en/2016.
[17] W. Abascal, E. Esteves, B. Goja, M.F. Gonzalez, A. Lorenzo, A. Sica, et al., Tobacco
control campaign in Uruguay: a population-based trend analysis, Lancet 380
(November (3)) (2012) 1575–1582, doi:http://dx.doi.org/10.1016/S0140-6736
(12)60826-5.[18] World Health Organization, WHO Report on the Global Tobacco Epidemic
Appendix V: Status of the WHO Framework Convention on Tobacco Control,
World Health Organization, 2015. http://www.who.int/tobacco/global_report/
2015/appendix5pdf?ua=12015.
[19] World Health Organization, Status of the WHO Framework Convention on
Tobacco Control, Appendix V, World Health Organization, 2013. (cited
2014 Aug 27) http://www.who.int/tobacco/global_report/2013/
appendix_vpdf?ua=12013.
[20] World Health Organization, WHO Report on the Global Tobacco Epidemic2015,
Appendix I: Regional Summary of MPOWER, (2015) . (cited 2015 Dec 28)
http://www.who.int/tobacco/global_report/2015/appendix1pdf?ua=1.
[21] Presidencia de la Nación- Ministerio de Salud, Panamerican Health
Organization PAHO, CDC. Global Adult Tobacco Survey, Fact Sheet Uruguay
2009. http://nccdcdcgov/GTSSData/Ancillary/DataReportsaspx?CAID=12011
[cited 2014 Aug 28].
[22] Presidencia de la Nación- Ministerio de Salud, INDEC, Panamerican Health
Organization PAHO, CDC. Global Adult Tobacco Survey; Fact Sheet Argentina
2012. http://nccdcdcgov/GTSSData/Ancillary/DataReportsaspx?CAID=12012
[cited 2014 Aug 28]; Available from: URL: http://nccd.cdc.gov/GTSSData/
Ancillary/DataReports.aspx?CAID=1.
[23] World Health Organization, WHO Report on the Global Tobacco Epidemic 2011,
Appendix IX-table 9.1. Global Youth Tobacco Survey Data, World Health
Organization, 2011 (12-9-2014).
[24] C.W. Warren, S. Asma, J.C. Lee, S. Lea, J. Mackay, The GTSS Atlas, CDC
Foundation, 2009 (12-9-201).
[25] B.A. King, S.A. Mirza, S.D. Babb, A cross-country comparison of secondhand
smoke exposure among adults: ﬁndings from the Global Adult Tobacco Survey
(GATS), Tob. Control 22 (July (4)) (2013), doi:http://dx.doi.org/10.1136/
tobaccocontrol-2012-050582 (e5-050582).
[26] R. Siegel, D. Naishadham, A. Jemal, Cancer statistics for Hispanics/Latinos, CA.
Cancer J. Clin. 62 (5) (2012) 283–298, doi:http://dx.doi.org/10.3322/
caac.21153.
[27] Barrios, E., Vasallo, J.A., Alonso, R., Garau, M., Musetti, C., III Atlas de Incidencia
de Cáncer en el Uruguay 2002–2006 [III Cancer Incidence Atlas in Uruguay
2002–2006]. http://www.bvsoncologiaorguy/pdfs/epidemiologia_en_cancer/
atlas_inciden_02_06pdf 2010February20 [cited 2014 Aug 10]; III.
[28] Panamerican Health Organization, Cancer in the Americas, Basic Indicators,
PAHO, 2013. (cited 2014 Aug 15) www.pahoorg/cancer/2014.
[29] D. Loria, J.J. Lence, M.E. Guerra, Y. Galán, E. Barrios, R. Alonso, et al., Tendencia
de la mortalidad por cáncer en Argentina, Cuba y Uruguay en un período de
15 años [Trends in mortality from cancer in Argentina, Cuba and Uruguay over
a period of 15 years], Revista Cubana de Salud Pública 36 (2) (2010) 115–125.
[30] V.J. Tovar-Guzman, F.J. Lopez-Antunano, N. Rodriguez-Salgado, Trends in
mortality from lung cancer in Mexico, 1980–2000, Rev. Panam. Salud Publica
17 (April (4)) (2005) 254–262.
[31] L.E. Bravo, T. Collazos, P. Collazos, L.S. Garcia, P. Correa, Trends of cancer
incidence and mortality in Cali, Colombia. 50 years experience, Colomb Med
(Cali) 43 (October (4)) (2012) 246–255.
[32] M.C. Yepez, L.E. Bravo, A. Hidalgo Troya, D.M. Jurado, L.M. Bravo, Cancer
incidence and mortality in the municipality of Pasto, 1, Colomb Med (Cali) 43
(October (4)) (2012) 256–266.
[33] C.A. Monteiro, T.M. Cavalcante, E.C. Moura, R.M. Claro, C.L. Szwarcwald,
Population-based evidence of a strong decline in the prevalence of smokers in
Brazil (1989–2003), Bull. World Health Organ. 85 (July (7)) (2007) 527–534
(S0042-96862007000700010[pii]).
[34] A.S. Szklo, L.M. de Almeida, V.C. Figueiredo, M. Autran, D. Malta, R. Caixeta,
et al., A snapshot of the striking decrease in cigarette smoking prevalence in
Brazil between 1989 and 2008, Prev. Med. 54 (February (2)) (2012) 162–167,
doi:http://dx.doi.org/10.1016/j.ypmed.2011.12.005 S0091-7435(11)00483-
[pii].
[35] Q. Cha, Y. Chen, Y. Du, The trends in histological types of lung cancer during
1980–1988, Guangzhou, China, Lung Cancer 17 (July (2–3)) (1997) 219–230.
[36] S.S. Devesa, F. Bray, A.P. Vizcaino, D.M. Parkin, International lung cancer trends
by histologic type: male:female differences diminishing and adenocarcinoma
rates rising, Int. J. Cancer 117 (November (2)) (2005) 294–299.
[37] J. Lortet-Tieulent, I. Soerjomataram, J. Ferlay, M. Rutherford, E. Weiderpass, F.
Bray, International trends in lung cancer incidence by histological subtype:
adenocarcinoma stabilizing in men but still increasing in women, Lung Cancer
84 (April (1)) (2014) 13–22, doi:http://dx.doi.org/10.1016/j.
lungcan.2014.01.009.
[38] B. Pesch, B. Kendzia, P. Gustavsson, K.H. Jockel, G. Johnen, H. Pohlabeln, et al.,
Cigarette smoking and lung cancer–relative risk estimates for the major
histological types from a pooled analysis of case-control studies, Int. J. Cancer
131 (Setember (5)) (2012) 1210–1219, doi:http://dx.doi.org/10.1002/ijc.27339.
[39] H. Rivas, A.F. Laureano, J. Serrano, C.M. Nazario, Lung and bronchus cancer in
Puerto Rico: changes in incidence and mortality rates by histology and sex
during 1987–2003, P. R. Health Sci. J. 30 (December (4)) (2011) 176–181.
[40] E.L. Wynder, J.E. Muscat, The changing epidemiology of smoking and lung
cancer histology, Environ. Health Perspect. 103 (Suppl. November (8)) (1995)
143–148.
[41] Gobierno de Chile-Ministerio de Salud. Encuesta Nacional de Salud 2009-2010.
http://www.dintacl/wp-dintacl/wp-content/uploads/Presentacion-ENSalud-
2010.pdf.2016 [cited 2016 Jan 4].
[42] C. Ferreccio, P.C. Gonzalez, S.V. Milosavjlevic, G.G. Marshall, A.M. Sancha, Lung
cancer and arsenic exposure in drinking water: a case-control study in
northern Chile, Cad. Saude Publica (Suppl. 3) (1998) 14 (193-8.:193-8).
M. Piñeros et al. / Cancer Epidemiology 44S (2016) S90–S99 S99[43] C. Ferreccio, C. Gonzalez, V. Milosavjlevic, G. Marshall, A.M. Sancha, A.H. Smith,
Lung cancer and arsenic concentrations in drinking water in Chile,
Epidemiology 11 (6) (2000 Nov) 673–679.
[44] C. Ferreccio, A.H. Smith, V. Duran, T. Barlaro, H. Benitez, R. Valdes, et al., Case-
control study of arsenic in drinking water and kidney cancer in uniquely
exposed Northern Chile, Am. J. Epidemiol. 178 (5) (2013) 813–818, doi:http://
dx.doi.org/10.1093/aje/kwt059 (Sep. 1).
[45] G. Marshall, C. Ferreccio, Y. Yuan, M.N. Bates, C. Steinmaus, S. Selvin, et al.,
Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic
in drinking water, J. Natl. Cancer Inst. 99 (June (12)) (2007) 920–928 (%20).
[46] C.M. Steinmaus, C. Ferreccio, J.A. Romo, Y. Yuan, S. Cortes, G. Marshall, et al.,
Drinking water arsenic in northern chile: high cancer risks 40 years after
exposure cessation, Cancer Epidemiol. Biomarkers Prev. 22 (April (4)) (2013)
623–630, doi:http://dx.doi.org/10.1158/1055-9965.EPI-12-1190.
[47] World Health Organization. Global Action Plan for the Prevention and Control
of Noncommunicable Diseases 2013–2020. http://appswhoint/iris/bitstream/
10665/94384/1/9789241506236_engpdf?ua=1. 2015 [cited 2015 Dec 29].
[48] V.C. Barbosa Filho, W. Campos, A.S. Lopes, Prevalence of alcohol and tobacco
use among Brazilian adolescents: a systematic review, Rev. Saude Publica 46
(October (5)) (2012) 901–917 (S0034-89102012000500018 [pii]).
[49] G.A. Giovino, J.E. Henningﬁeld, S.L. Tomar, L.G. Escobedo, J. Slade, Epidemiology
of tobacco use and dependence, Epidemiol. Rev. 17 (1) (1995) 48–65.
[50] D. Mendez, K.E. Warner, P.N. Courant, Has smoking cessation ceased? Expected
trends in the prevalence of smoking in the United States, Am. J. Epidemiol. 143
(August (3)) (1998) 249–258.
[51] L. Gruer, Tursan dE, S. Haw, E. Fernandez, J. Mackay, Smoke-free legislation:
global reach, impact and remaining challenges, Public Health 126 (March (3))
(2012) 227–229, doi:http://dx.doi.org/10.1016/j.puhe.2011.12.005 S0033-3506
(11)00394-5 [pii].
[52] J.F. Thrasher, E. Nayeli Abad-Vivero, E.M. Sebrie, T. Barrientos-Gutierrez, M.
Boado, H.H. Yong, et al., Tobacco smoke exposure in public places and
workplaces after smoke-free policy implementation: a longitudinal analysis of
smoker cohorts in Mexico and Uruguay, Health Policy Plan. 28 (8) (2013) 789–
798, doi:http://dx.doi.org/10.1093/heapol/czs118.[53] P. Jha, R. Peto, Global effects of smoking, of quitting, and of taxing tobacco, N.
Engl. J. Med. 370 (January (1)) (2014) 60–68, doi:http://dx.doi.org/10.1056/
NEJMra1308383.
[54] A.S. Szklo, J.F. Thrasher, C. Perez, V.C. Figueiredo, G. Fong, L.M. Almeida,
Understanding the relationship between socioeconomic status, smoking
cessation services provided by the health system and smoking cessation
behavior in Brazil, Cad Saude PublicaMar 29 (3) (2013) 485–495 (S0102-
311x2013000700007 [pii]).
[55] R. Valdes-Salgado, Progress and pending issues in the Latin American agenda
for tobacco control], Salud Publica Mex. 52 (Suppl. 2) (2010) (S321-9.:S321-
S329).
[56] M.J. Thun, J. Nilson, A. Liber, E. Blecher, The Global Tobacco Epidemic, in: B.W.
Stewart, C.P. Wild (Eds.), World Cancer Report, 2014, International Agency for
Research on Cancer, Lyon, 2014.
[57] A. Gigliotti, V.C. Figueiredo, C.S. Madruga, A.C. Marques, I. Pinsky, R. Caetano,
et al., How smokers may react to cigarette taxes and price increases in Brazil:
data from a national survey, BMC Public Health 14 (2014) 327, doi:http://dx.
doi.org/10.1186/1471-2458-14-327 (1471–2458-14-327 [pii]).
[58] R.I. Olivera-Chavez, R. Cermeno-Bazan, B.S. de Miera-Juarez, J.A. Jimenez-Ruiz,
L.M. Reynales-Shigematsu, [The effect of tobacco prices on consumption: a
time series data analysis for Mexico], Salud Publica Mex. 52 (Suppl. 2) (2010)
S197–S205 (S0036-36342010000800015 [pii]).
[59] L.M. Reynales-Shigematsu, N.L. Fleischer, J.F. Thrasher, Y. Zhang, R. Meza, K.M.
Cummings, et al., Effects of tobacco control policies on smoking prevalence
and tobacco-attributable deaths in Mexico: the SimSmoke model, Rev. Panam.
Salud Publica 38 (October (4)) (2015) 316–325 (S1020-49892015000900008
[pii]).
[60] L.H. Portes, C.V. Machado, WHO framework convention on tobacco control:
adherence and establishment in latin america, Rev. Panam. Salud Publica 38
(November (5)) (2015) 370–379 (S1020-49892015001000004 [pii]).
[61] E. Bianco, B. Champagne, J. Barnoya, The tobacco epidemic in Latin America
and the Caribbean: a snapshot, Prevention and Control 1 (2005) 311–317.
